FDA Inspection
Amarex Clinical Research, LLCAmarex Clinical Research, LLC – FDA Inspection, Dec 29, 2021
Record Details
This FDA Inspection record concerns Amarex Clinical Research, LLC, with an inspection on December 29, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 29, 2021
- Product Type
- Drugs
View Company Profile
ID · 80edfba9-eeed-43c3-b32e-9f45d770248f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1160749
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Amarex Clinical Research, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 3, 2021 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| December 5, 2017 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| January 28, 2015 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| January 11, 2010 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Amarex Clinical Research, LLC
- FDA Inspection 1158863 - 2021-11-03
- FDA Inspection 1035083 - 2017-12-05
- FDA Inspection 911612 - 2015-01-28
- FDA Inspection 637968 - 2010-01-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.